Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings / COZZI LEPRI, A; Phillips, An; MARTINEZ PICADO, J; Monforte, A; Katlama, C; EG HANSEN, Ab; Horban, A; Bruun, J; Clotet, B; Lichtner, Miriam; Lundgren, Jd; Vullo, Vincenzo; EUROSIDA STUDY, Group. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - 7:(2009), pp. 687-697. [10.1086/604731]
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
LICHTNER, Miriam;VULLO, Vincenzo;
2009
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
